Kaneka strengthens efforts to manufacture COVID-19 DNA vaccine candidate
Kaneka Eurogentec S.A. (Headquarters: Liège, Belgium), an affiliate of Kaneka Corporation (Headquarters: Minato-ku, Tokyo), signed an agreement with INOVIO Pharmaceuticals Inc. (Headquarters: Pennsylvania, US) to manufacture COVID-19 DNA vaccine candidate, INO-4800. INOVIO is ... biotechnology com